Skip to main content
. 2022 Apr 28;44(1):731–740. doi: 10.1080/0886022X.2022.2068442

Figure 2.

Figure 2.

The flow-chart of cases included in each step. One hundred and seventy-one cases were initially eligible, 10 cases of secondary MN, and 6 cases without glomerular PLA2R staining were excluded, and 125 cases were followed up and completed the study and analysis.